Certified by Founder Lodge
3E Bioventures Capital
China - Beijing, Haidian District
INVESTOR
1 Disclosed Funding Rounds $35,500,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
3E Bioventures Capital is a healthcare focused venture investment fund. The core 3E investment team members are all trained in biomedical fields, with healthcare industry experience and years
| Company | Date | Round | Raised |
|---|---|---|---|
 Larkspur Biosciences |
May, 24 ,2023 | Unknown | $35,500,000 |
 Smartlens |
July, 12 ,2023 | Series A | $6,100,000 |
 Myrobalan Therapeutics |
January, 11 ,2024 | Series A | $24,000,000 |
 Rapafusyn Pharmaceuticals |
June, 25 ,2024 | Series A | $28,000,000 |
 Acclaro Medical |
May, 30 ,2025 | Series B | $23,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Adronite | $5,000,000 | (Feb 20, 2026)
SPRX | $31,000,000 | (Feb 20, 2026)
Vizzia | $35,300,400 | (Feb 20, 2026)
Altesa BioSciences, Inc. | $75,000,000 | (Feb 20, 2026)
NuCube Energy | $13,000,000 | (Feb 20, 2026)
